SPY757.26−0.34%QQQ685.91−0.65%BTC/USD73,334.12−0.80%DIA524.71+0.05%GLD361.20−1.09%TLT81.04+0.15%

Macrogenics Inc

MGNXNASDAQ

Trade with Public

$2.32

-0.10-4.13%

Last update: Nov 11, 4:27 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Macrogenics (MGNX) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Macrogenics (MGNX) stock.

Analyst Consensus — 11 Analysts

1S.Buy

8Buy

2Hold

# Analysts11

Latest Upgrades and Downgrades for Macrogenics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$9→$11
—	Barclays	Etzer Darout	PT Raise	Overweight	$4→$6
—	B. Riley Securities	Mayank Mamtani	Upgrade	Neutral→Buy	$3→$9
—	Barclays	Etzer Darout	PT Raise	Overweight	$3→$4
—	HC Wainwright & Co.	Robert Burns	Maintained	Neutral	$2
—	Barclays	Etzer Darout	Assumes	Overweight	$3
—	Leerink Partners	—	PT Cut	Outperform	$8→$5
—	B. Riley Securities	Mayank Mamtani	PT Cut	Neutral	$5→$3
—	Stifel	Stephen Willey	PT Cut	Hold	$6→$5
—	Barclays	Peter Lawson	PT Cut	Overweight	$8→$3
—	HC Wainwright & Co.	Robert Burns	PT Cut	Neutral	$4→$2
—	JMP Securities	Silvan Tuerkcan	Downgrade	Market Outperform→Market Perform	—
—	HC Wainwright & Co.	Robert Burns	Maintained	Neutral	$4
—	HC Wainwright & Co.	Robert Burns	Maintained	Neutral	$4
—	HC Wainwright & Co.	Robert Burns	Maintained	Neutral	$4
—	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$16→$14
—	Stifel	Stephen Willey	PT Cut	Hold	$7→$6
—	BMO Capital	Etzer Darout	PT Cut	Market Perform	$8→$5
—	BTIG	Kaveri Pohlman	Downgrade	Buy→Neutral	—
—	HC Wainwright & Co.	Robert Burns	Maintained	Neutral	$4

Macrogenics Inc

Macrogenics (MGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Macrogenics Stock

Macrogenics (MGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Macrogenics Stock

Analyst Ratings News

PRO
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PRO
HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

4 Analysts Assess Macrogenics: What You Need To Know

PRO
B. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

People Also Watch

People Also Watch

Analyst Ratings News

PRO
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PRO
HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

4 Analysts Assess Macrogenics: What You Need To Know

PRO
B. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

Macrogenics Inc

Macrogenics (MGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Macrogenics Stock

Macrogenics (MGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Macrogenics Stock

Analyst Ratings News

PROB. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PROBarclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PROBarclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PROHC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

4 Analysts Assess Macrogenics: What You Need To Know

PROB. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

People Also Watch

People Also Watch

Analyst Ratings News

PROB. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PROBarclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PROBarclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PROHC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

4 Analysts Assess Macrogenics: What You Need To Know

PROB. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

PRO
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PRO
HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

PRO
B. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

PRO
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $6

PRO
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4

PRO
HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $2 Price Target

PRO
B. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3